Litigation Details for Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited (D. Del. 2015)
✉ Email this page to a colleague
Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-10-13 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | |
| Patents | 8,586,610; 9,138,432 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Vanda Pharmaceuticals Inc. v. Inventia Healthcare Limited (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-10-13 | 1 | infringement of a patent in the same family as the ’432 patent, namely U.S. Patent No. 8,586,610 (“the ’610…Page 2 of 10 PageID #: 2 U.S. Patent No. 9,138,432 (“the ’432 patent”), which relates to the field of…the ’432 patent, or any extensions thereof. Inventia will infringe claim 1 of the ’432 patent under 35… to the methods of the ’432 patent prior to the expiration of that patent, or any extensions thereof.…b) and (c) and 1400(b). IV. THE PATENT-IN-SUIT – U.S. PATENT NO. 9,138,432 14. | External link to document | |
| 2016-10-05 | 34 | Plaintiffs (Nos. 1-14) directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00921 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
